SIG BROKERAGE, LP
Broker-DealerPosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1094429
BALA CYNWYD, PA
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,722,798
+$564,172 QoQ
Shares Held
50,850
+32.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#281
of 671 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Dec 31, 2025CallValue
$780,250
CallShares
25,000
PutValue
$234,075
PutShares
7,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SIG BROKERAGE, LP holds $7,382,863 across 5 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (23.3% of the industry book) .
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,722,798 | 50,850 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,158,626 | 38,467 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $234,075 | 7,500 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $780,250 | 25,000 | Call | Sole | 2026-02-17 | |
| 2025-03-31 | $2,222,502 | 144,600 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $154,299 | 10,039 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,186,984 | 144,600 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $1,384,552 | 62,820 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||